Page 4 - Before Interest News Today

MYTILINEOS' growth trajectory enhanced by the synergies between Energy and Metallurgy

Pharma firm Laurus Labs reported a 25 percent fall in net profit for the March 2024 quarter. Net profit slipped to Rs 76 crore in the March 2024 quarter from Rs 102 crore in the year-ago period. The results were announced during market hours. The stock slipped up to 3.26% to Rs 420.20 after the earnings. Later, it closed 2.09% lower at Rs 425.30 on BSE. Revenue climbed 4 percent to Rs 1,439.67 crore in the last quarter from Rs 1,380.90 crore in the year ago period.

Indiva Remains the National Market Share Leader in the Edibles Category and Ranks #2 Nationally in Unit Share Across All Cannabis Categories ...

FORT WORTH, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (Nasdaq: FCFS), the leading international...

MYTILINEOS' growth trajectory enhanced by the synergies between Energy and Metallurgy

Laurus Labs Q4 earnings: A poll of brokerages had pegged the profit at Rs 107 crore

CINCINNATI, April 25, 2024 -- Phillips Edison & Company, Inc. , one of the nation’s largest owners and operators of grocery-anchored neighborhood shopping centers, today reported financial and...

Trading Update Q1 2024 Financial Performance A promising start for the year Delivering strong organic growth, we are...

Net Income of $107.7 Million and Earnings Per Share of $11.23 Petroleum Additives Shipments Up 4.7% Acquisition of American Pacific Corporation Completed in January ...

/PRNewswire/ -- Veris Residential, Inc. (NYSE: VRE) (the "Company"), a forward-thinking, environmentally and socially conscious multifamily REIT, today...